MISTI PATTILLO: Open Payments
NPI 1467494617 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 62 payments from 12 companies in 2025. Trend: 2023 $712 · 2024 $696 · 2025 $1,007
Food & beverage: $1,007
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $249 |
| E.R. Squibb & Sons, L.L.C. | 23 | $183 |
| CVRx, Inc. | 2 | $155 |
| Novartis Pharmaceuticals Corporation | 7 | $118 |
| Medtronic, Inc. | 1 | $106 |
| Alnylam Pharmaceuticals Inc. | 3 | $52 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Novo Nordisk Inc | 1 | $33 |
| BridgeBio Pharma, Inc. | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
Products named: VYNDAQEL, Barostim Neo System, ELIQUIS, LEQVIO, AURORA EV-ICD MRI SURESCAN, CAMZYOS, AMVUTTRA, VERQUVO.
Industry payments across AR — which companies pay providers there.
